Microparticles in multiple sclerosis and clinically isolated syndrome: Effect on endothelial barrier function

BMC Neuroscience

Volumn 15, Issue 1, 2014, Pages

  Marcos Ramiro, Beatriz ^a   Oliva Nacarino, Pedro ^b   Serrano Pertierra, Esther ^b   Blanco Gelaz, Miguel T ^b   Weksler, Babette B ^c   Romero, Ignacio A ^d   Couraud, Pierre O ^e   Tuñón, Alberto ^b   López Larrea, Carlos ^b   Millán, Jaime ^a   Cernuda Morollón, Eva ^b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d OPEN UNIVERSITY   (United Kingdom)

^e INSTITUT COCHIN   (France)

Author keywords

Clinically isolated syndrome; Endothelial barrier function; Microparticles; Multiple sclerosis; Thrombin

Indexed keywords

THROMBIN;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL BARRIER FUNCTION; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PLATELET MICROPARTICLE; THROMBOCYTE POOR PLASMA; ADOLESCENT; AGED; CAPILLARY PERMEABILITY; CHILD; COMPARATIVE STUDY; DEMYELINATING DISEASE; IMPEDANCE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; THROMBOCYTE; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CAPILLARY PERMEABILITY; CELL-DERIVED MICROPARTICLES; CHILD; DEMYELINATING DISEASES; ELECTRIC IMPEDANCE; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; THROMBIN; YOUNG ADULT;

EID: 84908121355     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-15-110     Document Type: Article

References (46)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000, 343:938-952. 10.1056/NEJM200009283431307, 11006371.
3. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990, 113(Pt 5):1477-1489.
4. Minagar A, Jy W, Jimenez JJ, Alexander JS. Multiple sclerosis as a vascular disease. Neurol Res 2006, 28:230-235. 10.1179/016164106X98080, 16687046.
5. Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, Jefferies WA, McQuaid S. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 2010, 229:180-191. 10.1016/j.jneuroim.2010.08.011, 20832870.
6. Brosnan CF, Raine CS. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996, 6:243-257. 10.1111/j.1750-3639.1996.tb00853.x, 8864282.
7. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002, 12:154-169.
8. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003, 201:319-327. 10.1002/path.1434, 14517850.
9. Leech S, Kirk J, Plumb J, McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 2007, 33:86-98.
10. Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, Etemadifar M, Steven Alexander J, Minagar A. Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation 2010, 7:10. 10.1186/1742-2094-7-10, 2829540, 20128908.
11. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008, 451:1076-1081. 10.1038/nature06559, 18278032.
12. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005, 4:281-288. 10.1016/S1474-4422(05)70071-5, 15847841.
13. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057. 10.1161/CIRCRESAHA.110.226456, 21030722.
14. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009, 335:143-151. 10.1007/s00441-008-0710-9, 18989704.
15. Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM, Tao J. Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens 2007, 20:957-964. 10.1016/j.amjhyper.2007.04.005, 17765136.
16. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014, 114:345-353. 10.1161/CIRCRESAHA.113.300858, 24436430.
17. Sellam J, Proulle V, Jungel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009, 11:R156. 10.1186/ar2833, 2787287, 19832990.
18. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006, 4:1296-1302. 10.1111/j.1538-7836.2006.01911.x, 16706974.
19. Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013, 11(Suppl 1):24-35.
20. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001, 56:1319-1324. 10.1212/WNL.56.10.1319, 11376181.
21. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 2008, 5:27. 10.1186/1742-2094-5-27, 2474601, 18588683.
22. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231. 10.1002/ana.410130302, 6847134.
23. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, Sturk A, Dignat-George F, Sabatier F, Camoin-Jau L, Sampol J, Hugel B, Zobairi F, Freyssinet JM, Nomura S, Shet AS, Key NS, Hebbel RP. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851. 10.1111/j.1538-7836.2004.00936.x, 15456497.
24. Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res 2013, 2013:734509. 3830876, 24288612.
25. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160. 10.1002/path.2287, 18161752.
26. Fernandez-Martin L, Marcos-Ramiro B, Bigarella CL, Graupera M, Cain RJ, Reglero-Real N, Jimenez A, Cernuda-Morollon E, Correas I, Cox S, Ridley AJ, Millan J. Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 2012, 32:e90-e102. 10.1161/ATVBAHA.112.252080, 22723439.
27. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
28. Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost 2009, 7(Suppl 1):122-126.
29. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003, 109:175-180. 10.1016/S0049-3848(03)00064-1, 12757771.
30. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 1995, 37:55-62. 10.1002/ana.410370111, 7529475.
31. Correale J, Bassani Molinas Mde L. Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS. J Neuroimmunol 2003, 140:198-209. 10.1016/S0165-5728(03)00204-2, 12864990.
32. Losy J, Niezgoda A, Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol 1999, 99:169-172. 10.1016/S0165-5728(99)00092-2, 10505971.
33. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011, 31:27-33. 10.1161/ATVBAHA.110.218123, 21160065.
34. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S, Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 2012, 110:1202-1210. 10.1161/CIRCRESAHA.111.256370, 3382058, 22456181.
35. Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 2010, 17:1083-1091. 10.1038/cdd.2009.179, 19927157.
36. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008, 173:1210-1219. 10.2353/ajpath.2008.080228, 2543087, 18772329.
37. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005, 25:1512-1518. 10.1161/01.ATV.0000170133.43608.37, 15890969.
38. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 2006, 26:2594-2604. 10.1161/01.ATV.0000246775.14471.26, 16990554.
39. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004, 286:H1910-H1915. 10.1152/ajpheart.01172.2003, 15072974.
40. Lozito TP, Tuan RS. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol 2012, 227:534-549. 10.1002/jcp.22744, 3205212, 21437907.
41. Canault M, Leroyer AS, Peiretti F, Leseche G, Tedgui A, Bonardo B, Alessi MC, Boulanger CM, Nalbone G. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol 2007, 171:1713-1723. 10.2353/ajpath.2007.070021, 2043531, 17872973.
42. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N. Monocytic microparticles activate endothelial cells in an IL-1beta-dependent manner. Blood 2011, 118:2366-2374. 10.1182/blood-2011-01-330878, 3162361, 21700772.
43. Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci (Lond) 2013, 124:423-441. 10.1042/CS20120309, 23249271.
44. Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE, Hirst MC, Sharrack B, Baker D, Male DK, Michael GJ, Romero IA. MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 2014, 28:2551-2565. 10.1096/fj.13-248880, 24604078.
45. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van Hinsbergh VW. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 1998, 83:1115-1123. 10.1161/01.RES.83.11.1115, 9831706.
46. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" . Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.